Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has received an average rating of “Buy” from the seventeen research firms that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $24.88.

A number of research analysts have recently commented on the company. JPMorgan Chase & Co. upped their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. KeyCorp started coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. Truist Financial upped their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Stephens reiterated an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently added to or reduced their stakes in PRVA. FMR LLC grew its position in shares of Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares during the last quarter. Geode Capital Management LLC grew its holdings in Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after purchasing an additional 23,178 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Privia Health Group by 2,994.2% during the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after purchasing an additional 1,101,730 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock worth $19,441,000 after purchasing an additional 173,934 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Trading Up 0.2 %

PRVA stock opened at $20.30 on Wednesday. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $23.78. The stock has a market cap of $2.44 billion, a PE ratio of 203.02, a P/E/G ratio of 5.45 and a beta of 0.85. The company has a 50-day moving average price of $20.80 and a 200 day moving average price of $19.38.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.